Montana’s SB535 is the first law in the nation allowing firms with successful Phase I trials to move directly to market — making our state a uniquely attractive home for biopharma. The planned Montana Innovation Corridor Gateway will feature a GMP-ready floor designed to support firms ready to take advantage of this unprecedented opportunity.
